CVR: 29829586
Secondary names: Drug Delivery Solutions ApS, Wynzora ApS, PAD Technology ApS
Previous names: TOXICELL ApS, DRUG DELIVERY SOLUTIONS ApS
DKK 4,813,840
Gross profit
Net result: DKK 6,548,744
MC2 Therapeutics A/S
CVR · view ownership and management
Director role ended: Jesper Jørn Lange
CVR · 27/05/2025
View the full event history
biomee ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DRUG DELIVERY SOLUTIONS ApS and TOXICELL ApS. The management consists of Trine Ahlgreen. The company is owned by MC2 Therapeutics A/S. In 2025, the company reported a gross profit of DKK 4,813,840 and a net result of DKK 6,548,744 compared with DKK 5,547,134 the year before. Equity in the 2025 report amounted to DKK 23,772,837.
Source: annual report 2025, Danish Business Authority
Biomee ApS exhibits strong financial health, marked by consistent profitability and significant growth in equity over recent years. Gross profit increased from 3.55 million DKK in 2022 to 4.81 million DKK in 2025, while profit rose from 3.6 million DKK to 6.55 million DKK in the same period, indicating a positive trend. The company's equity has surged from 207,609 DKK in 2021 to 23.77 million DKK in 2025, reflecting robust financial stability. However, the absence of disclosed revenue figures raises questions about overall sales performance. Positioned within the research and experimental development sector, biomee ApS demonstrates strong margins and a solid foundation for future growth.
AI-generated summary · Generated 16/08/2026
Selskabets formål er at drive virksomhed ved forskning, udvikling og handel indenfor biotek og anden hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 4.8 mio. | 6.5 mio. | 25.5 mio. | 23.8 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | 4.4 mio. | 5.5 mio. | 18.6 mio. | 17.2 mio. | - | |
| 202301/01/2023 – 31/12/2023 | 7.5 mio. | 7.9 mio. | 12.4 mio. | 11.7 mio. | - | |
| 202201/01/2022 – 31/12/2022 | 3.6 mio. | 3.6 mio. | 4.8 mio. | 3.8 mio. | - | |
| 202101/01/2021 – 31/12/2021 | 8.6 mio. | 7.8 mio. | 1.2 mio. | 208 t. | - | |
| 202001/01/2020 – 31/12/2020 | -461 t. | -2.8 mio. | 199 t. | -57.6 mio. | - | |
| 201901/01/2019 – 31/12/2019 | -273 t. | -2.4 mio. | 232 t. | -54.8 mio. | - | |
| 201801/01/2018 – 31/12/2018 | -386 t. | -2.4 mio. | 3.4 mio. | -52.4 mio. | 0 | |
| 201701/01/2017 – 31/12/2017 | -7.8 mio. | -4.2 mio. | 4.6 mio. | -50.1 mio. | - | |
| 201601/01/2016 – 31/12/2016 | -33 mio. | -38.7 mio. | 3.2 mio. | -45.8 mio. | - | |
| 201501/01/2015 – 31/12/2015 | -32.2 mio. | -33 mio. | 7.2 mio. | -7.1 mio. | - | |
| 201401/01/2014 – 31/12/2014 | -18.3 mio. | -17.2 mio. | 5 mio. | -78.7 mio. | - | |
| 201301/01/2013 – 31/12/2013 | -15.5 mio. | -18.6 mio. | 422 t. | -61.4 mio. | - | |
| 201201/01/2012 – 31/12/2012 | -11 mio. | -11.8 mio. | 1.9 mio. | -42.8 mio. | - |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringbiomee ApS was founded on 18 December 2006.
biomee ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
biomee ApS is owned by MC2 Therapeutics A/S.
In 2025, biomee ApS reported a gross profit of DKK 4,813,840.
The management of biomee ApS consists of Trine Ahlgreen.
biomee ApS is located at c/o MC2 Therapeutics A/S, Agern Alle 24, 2970 Hørsholm.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 53514153 (September 11, 2026).
As of September 1, 2026, Cedra Godkendt Revisionsaktieselskab has been appointed auditor of biomee ApS.
As of September 1, 2026, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of biomee ApS.
Biomee ApS has published its annual report for 2025. Gross profit came to DKK 4,813,840, and the net result was DKK 6,548,744.
Contact info changed: new phone: 53514153 (June 3, 2026).
Biomee ApS has published its annual report for 2024. Gross profit came to DKK 4,444,339, and the net result was DKK 5,547,134.
As of May 27, 2025, Trine Ahlgreen is registered as director of biomee ApS.
As of May 27, 2025, Jesper Jørn Lange has stepped down as director of biomee ApS.
Biomee ApS has published its annual report for 2023. Gross profit came to DKK 7,518,821, and the net result was DKK 7,867,031.
Biomee ApS has published its annual report for 2022. Gross profit came to DKK 3,551,834, and the net result was DKK 3,602,319.
Biomee ApS has published its annual report for 2021. Gross profit came to DKK 8,630,918, and the net result was DKK 7,786,490.
Biomee ApS has published its annual report for 2020. Gross profit came to DKK -461,055, and the net result was DKK -2,776,006.
On March 18, 2021, the company changed its name from DRUG DELIVERY SOLUTIONS ApS to biomee ApS.
Biomee ApS has published its annual report for 2019. Gross profit came to DKK -272,730, and the net result was DKK -2,353,230.
Biomee ApS has published its annual report for 2018. Gross profit came to DKK -386,013, and the net result was DKK -2,372,896.
Biomee ApS has published its annual report for 2017. Gross profit came to DKK -7,813,359, and the net result was DKK -4,230,706.
As of December 29, 2017, MC2 Therapeutics A/S is registered as an owner of biomee ApS with an ownership share of 100%.
Biomee ApS has published its annual report for 2016. Gross profit came to DKK -33,025,329, and the net result was DKK -38,706,747.
Biomee ApS has published its annual report for 2015. Gross profit came to DKK -32,170,559, and the net result was DKK -32,989,267.
Biomee ApS has published its annual report for 2014. Gross profit came to DKK -18,319,893, and the net result was DKK -17,231,020.
Biomee ApS has published its annual report for 2013. Gross profit came to DKK -15,514,659, and the net result was DKK -18,595,390.
Biomee ApS has published its annual report for 2012. Gross profit came to DKK -10,987,566, and the net result was DKK -11,767,871.
As of October 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of biomee ApS.
As of October 13, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of biomee ApS.
On December 17, 2008, the company changed its name from TOXICELL ApS to DRUG DELIVERY SOLUTIONS ApS.
As of December 18, 2006, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of biomee ApS.
As of December 18, 2006, Jesper Jørn Lange is registered as director of biomee ApS.
Biomee ApS was founded on December 18, 2006.
Companies in the same industry and area
CVR 29312206
CVR 37053678
CVR 37726028
CVR 29217939
CVR 31762863
